Curis
CRIS
#11081
Rank
$0.67 M
Marketcap
$0.35
Share price
-17.89%
Change (1 day)
-79.12%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -$6.76 Million USD

According to Curis's latest financial reports the company's current earnings are $7.06 Million USD. In 2025 the company made an earning of -$5.4 Million USD, an increase over its 2024 earnings that were of -$42.78 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -$6.76 Million25.24%
2025 -$5.4 Million-87.38%
2024 -$42.78 Million-5.77%
2023 -$45.4 Million-13.1%
2022 -$52.24 Million27.52%
2021 -$40.97 Million65.09%
2020 -$24.82 Million-9.1%
2019 -$27.3 Million-4.73%
2018 -$28.65 Million-41.95%
2017 -$49.36 Million-14.37%
2016 -$57.64 Million3.55%
2015 -$55.66 Million271.52%
2014 -$14.99 Million76.64%
2013 -$8.49 Million
2011 -$7.21 Million27.76%
2010 -$5.64 Million-43.87%
2009 -$10.05 Million-23.44%
2008 -$13.12 Million56.66%
2007 -$8.38 Million-16.71%
2006 -$10.06 Million-36.92%
2005 -$15.94 Million156.25%
2004 -$6.23 Million-37.24%
2003 -$9.92 Million-93.34%
2002 -$0.15 Billion86.79%
2001 -$79.68 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
$10.59 B-156,794.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$9.59 B-142,088.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-$61.89 Million 815.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
$1.00 B-14,942.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-$0.31 Billion 4,472.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-$22.2 Million 228.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$59.1 M-974.39%๐Ÿ‡บ๐Ÿ‡ธ USA